
Opinion|Videos|August 14, 2024
Adverse Event Profile & Management of Imetelstat
Author(s)Abdulraheem Yacoub, MD
Advertisement
Episodes in this series

- Please discuss the adverse event profile and AE management of imetelstat (telomerase inhibitor): o Patel K. June 13, 2024; P768 - EHA
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC
2
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
3
FDA Grants FTD to GPRC5D Bispecific LBL-034 for R/R Multiple Myeloma
4
Multiomic Real-World Data Predict Outcomes in Metastatic Breast Cancer
5


















